Atai Life Sciences Research and Development Expenses 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Atai Life Sciences Research and Development Expenses 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.5B
Quest Diagnostics (DGX)	$18B
DaVita (DVA)	$12.9B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.2B
Elanco Animal Health (ELAN)	$6.6B
RadNet (RDNT)	$5.9B
Option Care Health (OPCH)	$3.7B
Amedisys (AMED)	$2.9B
LifeStance Health (LFST)	$2.8B
Astrana Health (ASTH)	$2.3B
Addus HomeCare (ADUS)	$2.2B
U.S Physical Therapy (USPH)	$1.4B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Pennant (PNTG)	$1.1B
Daxor (DXR)	$43M
MEDIROM Healthcare Technologies (MRM)	$15M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$8M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M